Introduction: In late December 2019, a novel pneumonia case emerged in Wuhan, China, which was later identified by the WHO as COVID-19. Evaluating disease severity at the time of admission is crucial in reducing COVID-19 mortality. This study examines the effectiveness of the SOFA and qSOFA tools in predicting hospital mortality among ICU COVID-19 patients. Material and Methods: This comparative-descriptive study examined 205 severe and critical COVID-19 patients in the ICU. Data on demographics, clinical characteristics, and lab findings at admission were collected to calculate SOFA and qSOFA scores, correlated with in-hospital outcomes (survival or death). Analysis was conducted using SPSS software, with predictive accuracy assessed via ROC curve analysis. Results: Factors such as age ≥ 65, diabetes, hypertension, cardiovascular, cerebrovascular, and pulmonary diseases, elevated creatinine and bilirubin levels, reduced PaO2 levels, tachypnea, tachycardia, decreased SPO2 levels, increasing FiO2, high SOFA score, and qSOFA were significant in predicting mortality (P<0.05). The qSOFA score had an area under the curve of 0.983 (95% CI: 0.968-0.998), outperforming SOFA (95% CI: 0.885-0.959). SOFA did not significantly predict outcomes in the presence of other variables (P>0.05), whereas qSOFA did (P<0.05). Conclusion: Both SOFA and qSOFA effectively predicted COVID-19 outcomes, but qSOFA was superior in predicting mortality. Given its simplicity and suitability for routine use, qSOFA is more practical for everyday clinical application. |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |